The $875 level is a derived average rather than an official consensus figure. After reviewing 24 recent, attributable targets—including JPMorgan at $940 (Overweight), Goldman Sachs at $885 (Buy), Barclays at $880, Bank of America at $845, Piper Sandler at $850, Canaccord Genuity at $950, RBC Capital at $800, Rosenblatt at $900, and KeyBanc at $905—the mean came in near $874 and was rounded to $875. The spread remains broad, with Scotiabank at $650 (Sector Perform) on the low end and $1,000 at both Truist and Wells Fargo on the high end. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Most firms raised targets following the third-quarter results on the back of stronger advertising performance and clearer signs of AI monetization. A smaller group trimmed estimates, with TD Cowen moving to $830 and Piper Sandler easing to $850, while Wedbush and Scotiabank held more measured views. Aggregators such as S&P Global showed an average near $847 across 62 analysts, and MarketBeat reported near $833; the difference from the collected mean reflects the weight of recent upward revisions.
Meta closed at $620.19 on October 27, 2026, down from its 52-week high of $779.82 reached in late September and more than 17% lower over the prior month. Attaining $875 would imply roughly 41% upside, a sizable advance. Achieving that would likely require sustained mid-20% advertising revenue growth alongside greater investor confidence that heavy AI infrastructure outlays will translate into lasting earnings power.
Valuation appears reasonable on a trailing basis near 21 times earnings, yet the forward outlook is clouded by plans to roughly double capital expenditure into the $125–$145 billion range for 2026 and the emergence of negative free cash flow.
Third-quarter revenue climbed 26% year over year to $64.6 billion, exceeding expectations, supported by $63.1 billion in advertising revenue and fourth-quarter guidance of $73–$76 billion that also beat forecasts. The Muse AI assistant reached more than 10 million setups in the U.S. and Canada shortly after launch, and analysts at Citigroup and Deutsche Bank have projected potential Muse revenue in the billions by 2030. A generally constructive “Strong Buy” consensus, steady engagement across the platform family, and the company’s scale in AI talent and infrastructure bolster the constructive case.
Significant hurdles remain. GAAP EPS of $3.83 missed consensus in Q3, pressured by a $9.9 billion one-time legal charge. Free cash flow has moved into negative territory, and the planned equity program of roughly $95 billion, including a $35 billion immediate offering, raises dilution questions. Goldman Sachs projects free cash flow turning negative by about $33 billion in 2027, with capital expenditure approaching $230–$250 billion. Competition from OpenAI and Google in AI, ongoing regulatory scrutiny, and the possibility that Muse monetization falls short could all keep multiples under pressure.
The shares trade below both the 50-day and 200-day moving averages and sit about 17.5% below September’s all-time-high zone. The 100-day moving average has provided near-term support, and the stock has entered oversold territory with a 14-day RSI near 23. The $780–$787 area represents the prior record high and a key resistance zone on any recovery; a sustained close above it would mark an important technical step, whereas a break below the $520 52-week low would point to further weakness.
Most analyst targets reflect a roughly 12-month horizon, though individual time frames vary. Key items to monitor include quarterly advertising growth and operating margins, updates on Muse adoption and monetization, capital expenditure and free cash flow trends, progress on the equity raise, and regulatory developments. Revisions to forward EPS estimates, currently expected to move toward the mid-$30s, will offer an important signal on whether the consensus near $875 can be sustained.
Whether META can reach $875 hinges less on mathematical possibility and more on whether investors will continue to fund an AI buildout whose returns are not yet proven. The $875 level, a calculated average of two dozen analyst targets, sits roughly 41% above the latest price and above the consensus readings from major aggregators. Strong advertising momentum and early Muse traction support upside, while negative free cash flow, dilution, and heavy spending argue for caution. The wide $650-to-$1,000 analyst range underscores genuine uncertainty. Watching ad growth, margins, AI monetization, and cash flow will provide the next clues—no outcome is assured.
In my analysis of names like META, where sentiment can shift rapidly around earnings and AI developments, Tickeron’s AI Daily Buy/Sell Signals have proven helpful. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and changing market conditions. It allows more efficient tracking of opportunities and trends than manual review alone.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for META moved above the 200-day moving average on October 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +6.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where META advanced for three days, in 238 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
META may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on META as a result. In 56 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
The Moving Average Convergence Divergence Histogram (MACD) for META turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 27 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
META moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where META declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for META entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. META’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.048) is normal, around the industry mean (0.988). P/E Ratio (23.055) is within average values for comparable stocks, (-53.522). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (17.274). Dividend Yield (0.003) settles around the average of (0.976) among similar stocks. P/S Ratio (7.570) is also within normal values, averaging (71.888).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a social networking service and website
Industry InternetSoftwareServices